# Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency

> **NCT03776656** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 8 (actual)

## Conditions studied

- Adenylosuccinate Lyase Deficiency

## Interventions

- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT03776656
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2022-06-17
- **Final completion:** 2022-06-17
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776656, "Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03776656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*